enVVeno Medical (NVNO) Cash from Financing Activities (2017 - 2025)

enVVeno Medical's Cash from Financing Activities history runs 7 years deep, the most recent figure standing at $782000.0 for Q4 2025.

• On a quarterly basis, Cash from Financing Activities changed N/A year-over-year to $782000.0 in Q4 2025; TTM through Dec 2025 was $14.4 million, a 5.4% increase from a year earlier, with the FY2025 full-year figure at $1.0 million, down 92.5% from the prior year.
• Cash from Financing Activities slipped to $782000.0 in Q4 2025 per NVNO's latest filing, from $13.6 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $38.4 million in Q1 2021 and bottomed at -$4000.0 in Q4 2021.
• The 3-year median for Cash from Financing Activities is $7.2 million (2024), against an average of $12.0 million.
• Biggest YoY gain for Cash from Financing Activities was 6627.2% in 2021; the steepest drop was 100.06% in 2021.
• Year by year, Cash from Financing Activities stood at -$4000.0 in 2021, then soared by 339875.0% to $13.6 million in 2024, then plunged by 94.25% to $782000.0 in 2025.
• Per Business Quant, the three latest NVNO Cash from Financing Activities figures stand at $782000.0 (Q4 2025), $13.6 million (Q3 2024), and $46000.0 (Q1 2024).